Detalles de la búsqueda
1.
By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
J Virol
; 93(11)2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30918073
2.
Design and selection of anti-PD-L1 single-domain antibody and tumor necrosis factor superfamily ligands for an optimal vectorization in an oncolytic virus.
Front Bioeng Biotechnol
; 11: 1247802, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38053848
3.
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject 'cold' tumors.
J Immunother Cancer
; 10(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35058324
4.
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors.
Oncoimmunology
; 7(12): e1503032, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30524901
5.
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.
Oncoimmunology
; 7(12): e1386826, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30524877
6.
Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer.
Oncoimmunology
; 6(1): e1163456, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28197362
7.
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy.
Cancer Res
; 77(15): 4146-4157, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28536278
8.
Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment.
Oncoimmunology
; 5(2): e1080414, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27057460
9.
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition.
Oncoimmunology
; 5(10): e1220467, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27853644
10.
Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand.
Oncoimmunology
; 4(5): e1003013, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26155396
11.
Intravenous injection of MVA virus targets CD8+ lymphocytes to tumors to control tumor growth upon combinatorial treatment with a TLR9 agonist.
Cancer Immunol Res
; 2(12): 1163-74, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25168392
12.
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.
Nat Med
; 20(11): 1301-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25344738
13.
Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts.
PLoS One
; 8(9): e73310, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24019914
14.
TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy.
Oncoimmunology
; 1(8): 1271-1280, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23243590
Resultados
1 -
14
de 14
1
Próxima >
>>